{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:43:08Z","timestamp":1793317388287,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-technology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Technology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.slast.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:10:15Z","timestamp":1676851815000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-4922","authenticated-orcid":false,"given":"Alysia","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5854-6116","authenticated-orcid":false,"given":"Madelynn","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-2441","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Hallows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-5555","authenticated-orcid":false,"given":"Eun Ji","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.slast.2023.02.001_bib0001","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.slast.2023.02.001_bib0002","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.pap.0000163959.29032.1f","article-title":"Molecular basis of autosomal dominant polycystic kidney disease","volume":"12","author":"Al-Bhalal","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.slast.2023.02.001_bib0003","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1038\/s41467-020-18104-5","article-title":"Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo","volume":"11","author":"Cabrita","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.slast.2023.02.001_bib0004","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2215\/CJN.05651207","article-title":"Strategies to inhibit cyst formation in ADPKD","volume":"3","author":"Calvet","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.slast.2023.02.001_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000463063","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"van Gastel","year":"2017","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"10.1016\/j.slast.2023.02.001_bib0006","doi-asserted-by":"crossref","first-page":"49","DOI":"10.18632\/oncotarget.1548","article-title":"mTOR pathway in colorectal cancer: an update","volume":"5","author":"Francipane","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.slast.2023.02.001_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-018-4697-y","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in triple-negative breast cancer: a review","volume":"169","author":"Costa","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.slast.2023.02.001_bib0008","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12094-018-02012-8","article-title":"CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K\/AKT\/mTOR pathway","volume":"21","author":"Chen","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.slast.2023.02.001_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"Zhu, X. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci"},{"issue":"2","key":"10.1016\/j.slast.2023.02.001_bib0010","first-page":"15","article-title":"mTOR Inhibitors at a Glance","volume":"7","author":"Zheng","year":"2015","journal-title":"Mol Cell Pharmacol"},{"issue":"8","key":"10.1016\/j.slast.2023.02.001_bib0011","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/jcmm.13091","article-title":"Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1\/cyclin axis","volume":"21","author":"Li","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"12","key":"10.1016\/j.slast.2023.02.001_bib0012","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.slast.2023.02.001_bib0013","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/aps.2015.68","article-title":"Toward rapamycin analog (rapalog)-based precision cancer therapy","volume":"36","author":"Meng","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"10.1016\/j.slast.2023.02.001_bib0014","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14740338.2015.1040388","article-title":"Christians, U. Everolimus and sirolimus in transplantation-related but different","volume":"14","author":"Klawitter","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.slast.2023.02.001_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/lungindia.lungindia_280_19","article-title":"Sirolimus in lymphangioleiomyomatosis: a case in point for research in 'orphan' diseases","volume":"36","author":"Koul","year":"2019","journal-title":"Lung India"},{"issue":"9","key":"10.1016\/j.slast.2023.02.001_bib0016","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.slast.2023.02.001_bib0017","article-title":"Strategies to deliver RNA by nanoparticles for therapeutic potential","author":"Cox","year":"2021","journal-title":"Mol Aspect Med"},{"issue":"1","key":"10.1016\/j.slast.2023.02.001_bib0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12195-022-00753-9","article-title":"Combining metformin and drug-loaded kidney-targeting micelles for polycystic kidney disease","volume":"16","author":"Jiang","year":"2023","journal-title":"Cell Mol Bioeng"},{"issue":"3","key":"10.1016\/j.slast.2023.02.001_bib0019","doi-asserted-by":"crossref","first-page":"e10173","DOI":"10.1002\/btm2.10173","article-title":"The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles","volume":"5","author":"Huang","year":"2020","journal-title":"Bioeng Transl Med"},{"issue":"10","key":"10.1016\/j.slast.2023.02.001_bib0020","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1007\/s12274-018-2100-2","article-title":"Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery","volume":"11","author":"Wang","year":"2018","journal-title":"Nano Res"},{"key":"10.1016\/j.slast.2023.02.001_bib0021","article-title":"Nanoparticle-mediated microRNA-145 delivery for vascular smooth muscle cell phenotype modulation and atherosclerosis treatment","author":"Chin","year":"2020","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.slast.2023.02.001_bib0022","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.nano.2014.08.006","article-title":"In vivo biodistribution and clearance of peptide amphiphile micelles","volume":"11","author":"Chung","year":"2015","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.slast.2023.02.001_bib0023","first-page":"23","article-title":"Shape effects of peptide amphiphile micelles for targeting monocytes","author":"Joo","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.slast.2023.02.001_bib0024","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1681\/ASN.2018080816","article-title":"Vasopressin increases urinary acidification","volume":"30","author":"Giesecke","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.slast.2023.02.001_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1541-7786.MCR-12-0605","article-title":"Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis","volume":"11","author":"Guo","year":"2013","journal-title":"Mol Cancer Res"},{"issue":"7606","key":"10.1016\/j.slast.2023.02.001_bib0026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature17963","article-title":"Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor","volume":"534","author":"Rodrik-Outmezguine","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.slast.2023.02.001_bib0027","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.carbpol.2019.01.068","article-title":"Synergistic clearance of intracellular pathogens by hyaluronan-streptomycin micelles encapsulated with rapamycin","volume":"210","author":"Qiu","year":"2019","journal-title":"Carbohydr Polym"},{"issue":"1","key":"10.1016\/j.slast.2023.02.001_bib0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10717540802481307","article-title":"New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles","volume":"16","author":"Zou","year":"2009","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.slast.2023.02.001_bib0029","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/acs.biomac.9b01348","article-title":"\"Tandem\" nanomedicine approach against osteoclastogenesis: polysulfide micelles synergically scavenge ROS and release rapamycin","volume":"21","author":"El Mohtadi","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.slast.2023.02.001_bib0030","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3389\/fonc.2020.01012","article-title":"Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity","volume":"10","author":"La Manna","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.slast.2023.02.001_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.slast.2023.02.001_bib0032","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-200443020-00002","article-title":"Clinical pharmacokinetics of everolimus","volume":"43","author":"Kirchner","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.slast.2023.02.001_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00323-2","article-title":"The modular phosphorylation and activation of p70s6k","volume":"410","author":"Pullen","year":"1997","journal-title":"FEBS Lett"}],"container-title":["SLAS Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472630323000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472630323000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:09:35Z","timestamp":1762862975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472630323000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2472630323000110"],"URL":"https:\/\/doi.org\/10.1016\/j.slast.2023.02.001","relation":{},"ISSN":["2472-6303"],"issn-type":[{"value":"2472-6303","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"SLAS Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slast.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}]}}